Apr

17

Recent Advances in Nanotechnology

April 17, 2006 | 2 Comments

Motorized Nanocars, Nanogenerators, and Nanomedical Advances. ‘Cars made of a single molecule now are motorized, and mechanical energy from body movement is being harnessed to generate electricity and eventually, power implantable medical devices. These are just two of the nanotechnology breakthroughs announced in the past seven days. Nanotechnology is the science of creating or modifying [...]

Apr

16

Cancer: Photodynamic Therapy (PDT)

April 16, 2006 | Leave a Comment

Light activated anticancer drug targeted to DNA using cisplatin like sub-units: Coupling light absorbers to reactive metal centers. ‘One of the most effective chemotherapy drugs against cancer is cisplatin because it attaches to cancer DNA and disrupts repair. However, it also kills healthy tissue. Many scientists are creating alternative drugs or cisplatin analogs in attempts [...]

Apr

16

Potassium Channel Failure

April 16, 2006 | Leave a Comment

Unraveling the mysteries of poison. ‘Researchers from the Max Planck Institite for Biophysical Chemistry and other German and French colleagues have combined magnetic resonance spectroscopy (solid-state NMR) with special protein synthesis procedures to uncover how potassium channels and toxins combine and change in structure. This work could make it possible to develop medications for high [...]

Apr

16

Credibility Commons

April 16, 2006 | Leave a Comment

The Credibility Commons. ‘The Credibility Commons is an experimental environment enabling individuals the opportunity to try out different approaches to improving access to credible information on the World Wide Web. Tools will be provided to researchers as well as the public, allowing them to try out search strategies, collections and other approaches to improving access. [...]

Apr

14

D2OL Community Helps to Fight Avian Flu

April 14, 2006 | Leave a Comment

First Computational International Effort to Fight Avian Flu: The Rothberg Institute for Childhood Diseases (TRI), a non-profit research institute devoted to discovering and developing drugs to treat childhood diseases, today announced the release of the first avian influenza target to its Drug Design and Optimization Lab (D2OL) distributed computing project. Anyone with a personal computer [...]

« go back — keep looking »